Donia Boucher-Slimani

Donia Boucher-Slimani has extensive experience in the biotechnology industry. Donia currently holds the position of Director Business Development and Sales Enablement Cell and Gene Therapy Manufacturing at Oxford Biomedica since November 2022. Prior to this, they worked at MilliporeSigma for seven years, where they held various roles including Associate Director Business Development, Business Development Consultant, and Senior Data Analyst. Before joining MilliporeSigma, Donia worked at Merck Millipore as a Business Analyst in the Business Intelligence & Analytics department. Donia began their career as an Intern Junior Product Manager at General Electric Healthcare.

Donia Boucher-Slimani completed their Master of Science in Biotechnology from Grenoble INP - UGA from 2006 to 2009. Donia then pursued a Master's degree in Project Management, Marketing, International Business, Business Strategy, and Finance from Imperial College London in 2009-2010. In 2015-2016, Donia attended Harvard University for studies in Statistics. Additionally, in 2016, they attended the Massachusetts Institute of Technology for a Professional Education Short Program focused on Data and Models in Engineering, Science, and Business.